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Background. Overall, people with chronic illnesses have lower life satisfaction compared to nonclinical populations. The objective
of this international study was to examine the psychometric properties of the Satisfaction with Life Scale (SWLS) in patients with
Parkinson’s disease (PD). Methods. PD patients (𝑛 = 350) were recruited and interviewed at different specialized services in the
United Kingdom, Spain, Czech Republic, Italy, and The Netherlands. A questionnaire set including a measure of life satisfaction,
quality of life (QoL), self-reported health and disability status, and sociodemographic information was used. Acceptability,
reliability, and validity were examined. Results. The internal consistency was good (𝛼 = 0.81). The scale structure was satisfactory
(comparative fit index = 0.99; rootmean square error of approximation = 0.08).The SWLSwas able to discriminate between healthy
and unhealthy, disabled and nondisabled, and those perceiving a more severe impact of the disability on their lives. Concurrent
validity using multiple linear regressionmodels confirmed associations between SWLS and QoL and age. Conclusions.This study is
the first to report on the use of the SWLS in PD patients in different European countries. It is a useful tool in assessing satisfaction
with life in PD patients through the continuum of care.
1. Introduction
Parkinson’s disease (PD) is a common disease of unknown
etiology in elderly people and one of the major causes of
disability among elderly [1, 2]. Inmany cases, PD is associated
with disabilities, not only with physical disability, but also
with impairment and restrictions in emotional, cognitive,
and social functioning [3], whichmight affect life satisfaction.
The goal among people with chronic illnesses, most of which
are associated with disability, is to promote and maintain
subjective well being [4] and quality of life (QoL) [5, 6].
Subjective well being includes three distinct concepts: posi-
tive affect, negative affect, and life satisfaction [7]. The first
two concepts, as their names imply, refer to an emotional or
affective state, while life satisfaction is viewed as the cognitive
element, the area dealing with a person’s acquisition, process-
ing, and use of knowledge, all of which act in concert to shape
self-perceptions [4].
One of the scaleswidely used to appraise life satisfaction is
the Satisfaction with Life Scale (SWLS) [8].The psychometric
properties of the SWLS have been examined in different non-
clinical populations and less frequently in clinical samples [9].
Among clinical samples, the SWLS has been used in patients
with chronic illnesses, such as mental illness [10], systemic
lupus erythematosus [11], arthritis [12], and MS [13]; these
studies have reported lower life satisfaction scores (slightly
below average) compared to people without chronic illnesses.
Only a few studies [12, 13] have examined the psychometric
properties of the scale.
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To the best of our knowledge, no studies were found
investigating life satisfaction measured by the SWLS in PD
patients. Therefore, this study aimed to examine the psycho-
metric properties of the SWLS inPDpatients in fiveEuropean
countries. In addition, the correlates associated with life
satisfaction were examined.
2. Materials and Methods
2.1. Design and Procedure. A multicenter, cross-sectional
study was employed. This study was part of the DISQOL
Project funded by the European Commission Framework 6
Programme (number 513723). Detailed information of the
DISQOL Project has been reported elsewhere [14–17]. Five
out of 14 DISQOL centers, Edinburgh (United Kingdom),
Barcelona (Spain), Prague (Czech Republic), Sicily (Italy),
andTilburg (TheNetherlands), collected specific information
on PD.
2.2. Participants. Three hundred and fifty patients with a
diagnosis of idiopathic PD [18], cognitively intact on the
regular neurological examination performed at each partici-
pating center, andwilling to complete the study protocol were
included. Ethical approval was obtained from the Local Ethics
Committee at each participating center. All patients provided
written informed consent prior to their inclusion in the study.
2.3. Measures
2.3.1. Satisfaction with Life Scale (SWLS). The SWLS [8] is a
5-item measure for self-rated assessment of subjective well-
being.The questions have a 7-point Likert scale ranging from
“strongly disagree” to “strongly agree.” The total score ranges
from 5 to 35. A score of 20 represents the neutral point
on the scale (the point at which a respondent is neither
satisfied nor dissatisfied). Scores are categorized as very
high score: highly satisfied (30–35), high score (25–29), aver-
age score (20–24), slightly below average in life satisfaction
(15–19), dissatisfied (10–14), and extremely dissatisfied (5–
9) [8]. Mean life satisfaction scores across samples tend
to range from 23 to 28 [19]. The SWLS is reliable, has
a high internal consistency, is capable of discriminating
groups of presumed different subjective well-being lev-
els, and is efficient and easy to use [8, 9]. Versions
(English, Spanish, Czech, Italian, and Dutch) are available at
http://internal.psychology.illinois.edu/∼ediener/SWLS.html.
2.3.2. World Health Organization Quality of Life (WHOQOL).
The WHOQOL-BREF [20] and WHOQOL-DIS [14] are
instruments assessing QoL. The WHOQOL-BREF is a
genericQoL questionnaire comprising 24 items covering four
domains (physical and psychological health, social relation-
ships, and environment) and two questions about overall
QoL (q1. “How would you rate your QoL?”) and satisfaction
with health (q2. “How satisfied are you with your health?”).
The WHOQOL-DIS is a supplementary module comprising
12 items that function as a single overall domain. In both
measures, items have a 5-point Likert-type response format;
scores range from 4 to 20, with higher scores representing
higher QoL. Both theWHOQOL-BREF and theWHOQOL-
DIS modules have the same time frame (i.e., the past two
weeks).
2.3.3. Sociodemographic, Health, and Disability Informa-
tion. In addition, participants provided sociodemographic
information on gender, age, marital status, and educa-
tion, as well as information about their subjective percep-
tion of (1) health status: are you currently ill or in poor
health? yes/no; (2) disability: do you believe you have a
disability? yes/no; (3) the impact the disability had in life:
how much does this disability affect your life? hardly
at all/mildly/moderately/severely/profoundly. All information
was self-reported.
2.4. Statistical Analysis. Descriptive statistics were calculated
for the demographic variables (i.e., age, gender, marital
status, and education), the SWLS items and total score over-
all QoL, satisfaction with health, self-perception of health
(healthy/unhealthy), and disability status (disabled/non-
disabled). Floor and ceiling effects would be present if more
than 15% of respondents achieved the lowest or highest possi-
ble score [21, 22]. Reliability was assessed on the basis of inter-
nal consistency (Cronbach’s alpha coefficients ≥ 0.70) [23].
Validity analyses were done by construct, concurrent, and
discriminant validity approaches. Confirmatory factor anal-
ysis (CFA) and known groups validity approaches were used
for construct validity testing. CFA was conducted to test
whether the original unidimensional structure of the SWLS
is suited to Parkinson’s disease. The errors of each item were
not correlated with each other and the factor variance was
set at 1. Goodness of fit was verified by the following fit
indices: the comparative fit index (CFI) and the root mean
square error of approximation (RMSEA). The models have
a satisfactory to good fit when CFI is at least 0.95 [24] and
RMSEA values as high as 0.08 are expected to be reasonable
in the PD population [25]. Concurrent validity of SWLS was
also tested by multiple linear regression analyses by using
WHOQOL-BREF’s single items: general perceived QoL item
(q1. How would you rate your QoL?) and self-rated satisfac-
tion with health item (q2. How satisfied are you with your
health?), the WHOQOL-BREF domains (physical health,
psychological health, social relationships, and environment),
and the WHOQOL-DIS. Effect-size statistics [23] were used
for the pairwise comparisons of the ordinal SWLS categories
(extremely satisfied to extremely dissatisfied) in regard to
WHOQOL domain scores as an alternative way of showing
the concurrency of SWLS and WHOQOL.
Age, gender, marital status, and education were used for
testing the known groups validity of the SWLS. Student’s
t-tests, one-way analysis of variance (ANOVA), and post
hoc Scheffé test were used to examine group differences.
Discriminant validity was shown by indicating the difference
of SWLS scores between healthy and unhealthy people and
disabled and nondisabled people. A 𝑃 value of <0.05 was
regarded as statistically significant. All statistical calculations
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were performed with SPSS for Windows v19.0; CFA was
performed with Lisrel version 8.05.
3. Results and Discussion
3.1. Participants. The mean total SWLS score was 21.1 (SD:
6.7); no significant differences were found on SWLS total
scores between centers. However, all centers except Prague
had an average total score of 20–24; PD patients from Prague
were slightly dissatisfied with life (15–19). Overall mean age
was 66.5 (SD = 9.7, range 34–91); patients from Prague were
younger than those fromEdinburgh and Barcelona (F(4, 342)
= 3.41, 𝑃 = 0.009). No significant differences were found
among gender (Table 1).
Sicily patients had the lowest overall QoL, but significant
differences were only found with patients from Edinburgh
(F(4, 345) = 3.22, 𝑃 = 0.013). Patients with PD from Prague
had the lowest satisfaction with health, but significant differ-
ences were only found with patients from Edinburgh (F(4,
345) = 3.05, 𝑃 = 0.018). Most patients from Sicily and
Barcelona reported that they were ill/unhealthy (𝜒2(4) =
34.61, 𝑃 < 0.001). About 90% or more of the participants
reported being disabled, with the exception of Barcelona
(67.7%) (𝜒2(4) = 24.02, 𝑃 < 0.001) (Table 1).
3.2. Descriptive Statistics. No items showed floor or ceiling
effects; we found 0.9% at floor and 0.3% at ceiling. Missing
information varied from 1.9% (item 3) to 2.5% item 1.
3.3. Reliability. Cronbach’s alpha coefficient was 0.81 for
the total sample and varied between centers, from 0.74
(Barcelona) to 0.88 (Tilburg). Deleting items would not result
in improvement in the internal consistency. The 𝜒2 value of
this model was 15.25 (df = 5, 𝑃 = 0.00936). The CFA results
indicated acceptable scale structure via quite satisfactory fit
indices (CFI = 0.99; RMSEA = 0.077); error variance was also
found acceptable (between 0.20 and 0.85) for each of the items
(Figure 1).
3.4. Discriminant Validity. In relation to known groups, PD
patients younger than 65 scored significantly lower than those
65 and older (𝑡(345) = −3.398, 𝑃 = 0.001). No differences
were found for gender, marital status, or education (Table 2).
The SWLS was able to discriminate between healthy
and unhealthy participants (𝑡(346) = 4.52, 𝑃 < 0.001),
disabled and nondisabled (𝑡(346) = 2.72, 𝑃 = 0.007), and
those withmild versus severe impact of the disability on their
lives (𝑡(308) = 5.36,𝑃 < 0.001).Healthy participants, nondis-
abled, and those reporting a mild effect of the disability on
their lives scored significantly higher on life satisfaction than
ill/unhealthy, disabled, and participants reporting a severe
impact of the disability on their lives. Yet, only ill/unhealthy
and those reporting a severe impact of the disability on their
lives fell in the category of slightly dissatisfied. In addition, the
SWLS scores decreased as impact disability in life increased;
SWLS scores were 27.86 (SD = 6.33) for those reporting no
impact (hardly at all), 24.44 (SD = 6.15) for those reporting a
mild impact, 21.21 (SD = 6.00) for those reporting amoderate
S1 ideal
S2 condi
S3 satis
S4 impor
S5 chang
0.438
0.449
0.354
0.710
0.752
0.803
0.538
0.498
1.000
0.749
0.742
SWLS
root mean square error of approximation = 0.077; comparative
fit index = 0.986;
2
= 15.25;Df = 5; P = 0.0094;
→ error variance,
← std.regression coeff.
Figure 1: Confirmatory factor analysis results for one factor 5-item
SWLS.
impact, and 19.47 (SD = 6.06) and 17.21 (SD = 6.85) for those
reporting severe and profound impact, respectively (F(4, 305)
= 13.73, 𝑃 < 0.001).
3.5. Concurrent Validity. The two independent questions of
the WHOQOL (q1. How would you rate your QoL? and q2.
How satisfied are you with your health?), the four domains of
the WHOQOL-BREF (physical health, psychological health,
social relationships, and environment) and the WHOQOL-
DIS were used in the analyses of concurrent validity of
SWLS as shown in the Table 3. All of the regression models
(models 8–14) in which total SWLS score is compared with
WHOQOL-BREF’s overall QoL (q1), health satisfaction (q2)
items, the four domains, and the WHOQOL-DIS showed
very satisfactory standardized beta values, indicating that the
variances of WHOQOL could be sufficiently explained by
the overall SWLS score. On the other hand, models 1–7 were
conducted to see the concurrence of the individual items
of the SWLS on the WHOQOL-BREF and the WHOQOL-
DIS. All of the items were found very sensitive to all of
the WHOQOL-BREF domains. The physical domain of the
WHOQOLwas not sensitive to the 3rd itemof the SWLS (sat-
isfiedwith life). It was also interesting to find that the variance
of the environmental domain was significantly explained
by all SWLS items except for the 1st item (Life close to ideal).
Satisfactory effect sizes (greater than 0.2) were obtained for
almost all of the adjacent SWLS categories (Table 4).
4. Discussion
The aim of this study was to explore the psychometric
properties of the SWLS in peoplewith PD and assess variables
associated with SWLS across five European centers. The
4 The Scientific World Journal
Table 1: SWLS scores, age, and other health variables by centre.
Edinburgh
𝑁 = 123
Barcelona
𝑁 = 65
Prague
𝑁 = 32
Sicily
𝑁 = 26
Tilburg
𝑁 = 104
Testdf∗ , sig
SWLS: mean (SD) 21.1 (6.1) 21.3 (6.2) 18.5 (7.1) 21.2 (7.0) 21.8 (7.5) 𝐹(4,345) 1.469, 0.211
Age years: mean (SD) 67.1 (8.5) 68.8 (9.9) 61.6 (8.8) 64.6 (10.7) 66.7 (10.2) 𝐹(4,342) 3.414, 0.009
Male: 𝑛 (%) 63 (51.2) 34 (52.3) 21 (65.6) 18 (69.2) 60 (57.7) 𝜒2(4) 4.672, 0.323
Married: 𝑛 (%) 90 (73.2) 48 (73.8) 28 (90.3) 24 (93.2) 86 (84.3) 𝜒2(4) 10.608, 0.031
College and university education: 𝑛 (%) 53 (43.1) 16 (24.6) 16 (50.0) 4 (15.4) 39 (37.5) 𝜒2(4) 13.816, 0.008
Overall QOL1: mean (SD) 3.5 (0.9) 3.3 (0.8) 3.4 (0.6) 2.9 (1.0) 3.3 (0.9) 𝐹(4,345) 3.220, 0.013
Satisfaction with health2: mean (SD) 2.9 (1.0) 2.8 (1.0) 2.2 (0.8) 2.8 (1.0) 2.7 (0.9) 𝐹(4,345) 3.047, 0.018
Ill health/unhealthy: 𝑛 (%) 53 (43.4) 52 (80.0) 17 (53.1) 23 (88.5) 54 (52.4) 𝜒2(4) 34.606, <0.001
Disabled: 𝑛 (%) 108 (87.8) 44 (67.7) 31 (97.0) 27 (90.0) 95 (93.1) 𝜒2(4) 24.020, <0.001
1Overall QoL (q1). “How would you rate your QoL?.”
2Satisfaction with health (q2). “How satisfied are you with your health?.”
∗df: degrees of freedom.
Table 2: Known groups comparisons and discriminant validity
results. 𝑛 = 350.
SWLS: score
mean (sd1) 𝑡-test, df
2; 𝑃 value
Known groups
Gender
Male 21.6 (7.0) 1.680, 348; 0.089
Female 20.4 (6.2)
Group age
<65 years 19.5 (6.7)
−3.398, 345; 0.001
≥65 years 22.0 (6.5)
Marital status: 𝑛 (%)
Other 20.0 (6.5)
−1.500, 345; 0.135
Married 21.4 (6.7)
Education: 𝑛 (%)
Primary school
or less 20.3 (6.6) −0.924, 346; 0.356
Secondary school
and higher 21.2 (6.7)
Discriminant validity comparisons
Self-reported health
Healthy 23.0 (6.5) 4.517, 346; <0.001
Ill/unhealthy 19.8 (6.5)
Self-reported
disability
No 23.5 (6.3) 2.717, 346; 0.007
Yes 20.7 (6.6)
Disability effect in life
Mildly and
moderately 22.7 (6.4) 5.363, 308; <0.001
Severely and
profoundly 18.6 (6.3)
1sd: standard deviation, 2df: degrees of freedom.
SWLS is a useful tool to be used with other measures to
provide valuable information throughout the continuum of
care on people with PD, from early diagnosis to late phases
of the disease; the information obtained might serve to guide
the evaluation and clinical decision making of professionals,
the effectiveness of care, and service delivery, in both health
and social care. Also, the information might prove useful for
policymakers; improvement of welfare systems, transporta-
tion, housing, access to leisure activities, and adaptation of
working environment regulations [15] are nonclinical aspects
which might contribute to a better degree of wellbeing and
life satisfaction.
In terms of reliability, SWLS showed acceptable levels
of internal consistency for the total sample (0.81) at each
participating center (range 0.74 to 0.88). Although there
is, in the literature, a considerable degree of variability
across samples, generally, the levels of internal consistency
are around 0.80 [19]. Our findings are quite similar and
comparable to those reported previously in clinical samples
[11–13] and population based studies [26–28]. CFA confirmed
that a single-factor solution model reveals an adequate fit on
the basis of model fit indices (RMSEA and CFI). This result
also supported previous findings reported from factor anal-
yses [12, 13, 26–32] and confirmed the hypothesized factor
structure for the SWLS [8]. In our sample, items 4 and 5
had weaker association with satisfaction of life than items 1–3
consistent with findings reported in previous studies [27, 30].
In addition to factorial structure, the SWLS was found
to have good concurrent and discriminant validity. Previous
studies using the SWLS with QoL and health-related QoL
measures reported moderate-high correlations between both
constructs. For example, statistically significant positive cor-
relations were reported between the SWLS and all SF-36
domains in patients with systemic lupus erythematous [11]
and among the SWLS, the WHOQOL-BREF domains, and
WHOQOL-DIS in patients with multiple sclerosis [13].
Also, statistically significant negative correlations were found
between the SWLS and the Hospital Anxiety and Depression
Scale in people with MS [13].
In relation to the discriminant validity, patients with
systemic lupus erythematous [11] and patients with multiple
sclerosis reporting a more severe effect of disability on their
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Table 3: Concurrent validity 1: multiple linear regression models’ results for SWLS-dependent variables are WHOQOL general perceived
quality of life (q1), self-rated health (q2), fourWHOQOL-BREF dimensions (physical, psychological, social relationships, and environmental
well-being), and WHOQOL disability module.
Dependent variables
Overall
QoL1
Self-rated
health2
Physical health
(WHOQOL)
Psychological
health
(WHOQOL)
Social
relationships
(WHOQOL)
Environment
(WHOQOL)
WHOQOL
disability
module
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7
Beta Beta Beta Beta Beta Beta
(Constant) 𝑃 < 0.001 𝑃 = 0.01 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001
Age −0.05 0.02 −0.002 −0.12∗ −0.10∗ −0.10∗ −0.19∗∗
S1 In most ways my life
is close to my ideal 0.03 0.05 0.11 0.07 0.05 −0.04 0.02
S2The conditions of my
life are excellent 0.20
∗∗ 0.08 0.12 0.02 −0.001 0.21∗∗ 0.12∗
S3 I am satisfied with my
life 0.36
∗∗ 0.37∗∗ 0.12 0.35∗∗ 0.24∗∗ 0.18∗∗ 0.15∗
S4 So far I have gotten
the important things I
want in life
0.02 0.04 0.14∗ 0.07 0.17∗∗ 0.24∗∗ 0.09
S5 If I could live my life
over, I would change
almost nothing
−0.04 0.07 0.06 0.08 0.12∗ 0.11∗ 0.16∗∗
Model 8 Model 9 Model 10 Model 11 Model 12 Model 13 Model 14
(Constant) 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001
Age −0.073 0.01 −0.01 −0.13∗ −0.11∗ −0.10∗ −0.18∗∗
Total SWLS 0.46∗∗ 0.48∗∗ 0.41∗∗ 0.46∗∗ 0.43∗∗ 0.52∗∗ 0.40∗∗
∗
𝑃 < 0.05.
∗∗
𝑃 < 0.001.
1Overall QoL (q1). “How would you rate your QoL?.”
2Satisfaction with health (q2). “How satisfied are you with your health?.”
Table 4: Concurrent validity 2: pairwise comparisons of the SWLS categories in regard to WHOQOL domain scores.
Comparison of the SWLS categories∗
WHOQOL domains 1 versus 2ES∗∗ 2 versus 3 3 versus 4 4 versus 5 5 versus 6 1 versus 6
Physical health 0.69 0.39 0.13 0.25 0.63 1.63
Mental health 0.62 0.29 0.25 0.34 0.75 1.69
Social relationships 0.03 0.38 0.21 0.44 0.56 1.34
Environmental 0.19 0.53 0.12 0.30 0.83 1.90
∗
1: extremely dissatisfied; 2: dissatisfied; 3: slightly dissatisfied; 4: neutral/average; 5: slightly satisfied; 6: extremely/highly satisfied.
∗∗ES (Cohen’s effect size): difference between means divided by pooled standard deviation; interpretation: 0.2: small, 0.5: medium, 0.8: large.
life [13] had lower scores in both health-related quality of life
and satisfaction with life.
The SWLS was able to discriminate between participants
on the basis of their health perception (healthy versus
unhealthy), disability status (disabled versus nondisabled)
and impact of disability on their lives. Although SWLS scores
were higher for healthy, nondisabled, and those reporting less
impact of the disability in their life, only the former and the
last groups scored slightly below average in life satisfaction
(15–19). Patients with systematic lupus erythematous [11],
arthritis [12], and multiple sclerosis [13] and people in the
general population with a mental diagnosis in the previous
12 months [10] also scored below average in life satisfaction.
However, none of these studies reported information in
relation to the percentage of participants being extremely dis-
satisfied, dissatisfied, average, or satisfied. This information
is important because depending on the source of the dissat-
isfaction, measures might exist that can be taken to improve
life satisfaction in clinical populations.
Pairwise comparisons of the 1st versus 2nd (extremely
dissatisfied versus dissatisfied) and 5th versus 6th (slightly
satisfied versus extremely/highly satisfied) SWLS categories
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in regard to WHOQOL-BREF domain scores yielded mean-
ingful (>0.50) effect-size figures compared to those of
comparisons of the middle descriptors (i.e., 2nd, 3rd, 4th,
and 5th descriptors). Physical and psychological domains
of the WHOQOL-BREF can better discriminate the 1st
versus 2nd categories than the remaining two domains of
the WHOQOL-BREF (see Table 4). These findings may be
evidence of nonlinear association between life satisfaction
and quality of life in the PD patients.
We did not find a linear pattern of lower life satisfaction
with increasing years of disability; however, we found that
life satisfaction decreased as the impact of disability in life
increased.Whereas it has been reported that PDpatientswere
generally satisfied with the care they received, especially that
from movement disorder specialists [33], it has been also
suggested that “improving recognition of the period of
preclinical disability will enable better timing of therapies to
delay the onset of disability in PD” [34].
People with disabilities experience more barriers with
access to health and social services as well as social and other
environmental barriers [13, 15, 17] than the general popula-
tion. Thus, barriers might be a source of life dissatisfaction
in PDpatients. From a social point of view and social policies,
this information is important because in some cases, PD
patients with disabilities might have further benefits in life
improvement and life satisfaction from social and environ-
mental policies apart from health policies. For example,
implementation of social and environmental policies related
to access to public transportation and availability of special
transport when needed, ramps; easy access to places for
leisure activities (e.g., cinemas, theaters, and restaurants);
support for going on vacation; financial support fromgovern-
ment, which have been shown to be important for QoL of PD
patients [15, 17], might increase as well their life satisfaction.
This might be reflected on the association found between
the SWLS and the environmental domain of the WHOQOL-
BREF which includes items related to health care access,
transport, environment, and financial resources.
Compared to studies which assessed life satisfaction with
the SWLS in elderly people [27, 32], we found lower SWLS
scores in PD patients in all participating centers. Our results
reveal that PD has a great influence on the patients’ quality
of life as well as their satisfaction with life. Overall, these
findings not only confirm the relationship between life satis-
faction and QoL, but also show the distinctiveness between
them, suggesting that QoL and life satisfaction may be
assessed separately to enable a full examination of the
patient’s state [11].
Study limitations include the following: (1) we used
a targeted population; (2) the information which usually
characterizes PD patients, as Hoehn-Yahr scores and UPDRS
scores, was not recorded in all centers; (3) patients with mild
cognitive impairment, commonly found in people with PD,
were not included; (4) we did not examine the test-retest
reliability. Despite these limitations, in the light of our find-
ings, the SWLS was found to be acceptable and reliable and
shows evidence of validity in patients with PD.
5. Conclusion
In conclusion, the results revealed that the psychometric
properties of the SWLS were satisfactory. In addition, the
results confirmed that the SWLS is suitable to use cross-
culturally in patients with PD.The use of the SWLS incorpo-
rated during routine visits and in future longitudinal studies
will help to determine its sensitivity over time to disease pro-
gression and disability and to different therapeutic interven-
tions (pharmacological, psychological, physiotherapy, and
surgical) or implementation of different health and social
service provision or improvement in environmental policies.
To our knowledge, this is the first study using the SWLS cross-
culturally in people with PD in several European countries,
thus, adding evidence of its validity in a population who was
clearly warranted [11].
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